Noxious heat-induced CGRP release from rat sciatic nerve axons in vitro.
Noxious heat may act as an endogenous activator of the ionotropic capsaicin receptor (VR1) and of its recently found homologue VRL1, expressed in rat dorsal root ganglion cells and present along their nerve fibres. We have previously reported that capsaicin induces receptor-mediated and Ca++-dependent calcitonin gene-related peptide (CGRP) release from axons of the isolated rat sciatic nerve. Here we extended the investigation to noxious heat stimulation and the transduction mechanisms involved. Heat stimulation augmented the CGRP release from desheathed sciatic nerves in a log-linear manner with a Q10 of approximately 15 and a threshold between 40 and 42 degrees C. The increases were 1.75-fold at 42 degrees C, 3.8-fold at 45 degrees C and 29.1-fold at 52 degrees C; in Ca++-free solution these heat responses were abolished or reduced by 71 and 92%, respectively. Capsazepine (10 microm) and Ruthenium Red (1 microm) used as capsaicin receptor/channel antagonists did not significantly inhibit the heat-induced release. Pretreatment of the nerves with capsaicin (100 microm for 30 min) caused complete desensitization to 1 microm capsaicin, but a significant heat response remained, indicating that heat sensitivity is not restricted to capsaicin-sensitive fibres. The sciatic nerve axons responded to heat, potassium and capsaicin stimulation with a Ca++-dependent CGRP release. Blockade of the capsaicin receptor/channels had little effect on the heat-induced neuropeptide release. We conclude therefore that other heat-activated ion channels than VR1 and VRL1 in capsaicin-sensitive and -insensitive nerve fibres may cause excitation, axonal Ca++ influx and subsequent CGRP release.
Sauer
S K
SK
Department of Physiology and Experimental Pathophysiology, University of Erlangen, Universitätsstr. 17, D-91054 Erlangen, Germany. sauer@physiologie1.uni-erlangen.de
Reeh
P W
PW
Bove
G M
GM
D000818:Animals; D001369:Axons / Q000378:metabolism*; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism*; D002211:Capsaicin / Q000819:agonists / Q000031:analogs & derivatives* / Q000494:pharmacology; D004396:Coloring Agents / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005727:Ganglia, Spinal / Q000378:metabolism* / Q000503:physiopathology; D006358:Hot Temperature / Q000009:adverse effects; D008297:Male; D009619:Nociceptors / Q000378:metabolism*; D010146:Pain / Q000378:metabolism* / Q000503:physiopathology; D011188:Potassium / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011955:Receptors, Drug / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012430:Ruthenium Red / Q000494:pharmacology; D012584:Sciatic Nerve / Q000378:metabolism* / Q000503:physiopathology
D004396:Coloring Agents; D011955:Receptors, Drug; D012430:Ruthenium Red; D015740:Calcitonin Gene-Related Peptide; C071423:capsazepine; D011188:Potassium; D002211:Capsaicin